700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Original Articles Open Access
Alzheimer´s disease (AD) is a progressive and irreversible neurological disorder associated with age-related dementia. Extracellular deposition of fibrils derived from b-amyloid peptide (Ab) is one of the most important pathological hallmark of AD. Here we present results concerning the investigation of the in vitro inhibitory effect of the quinolones levofloxacin (3) and 3-carboethoxy-4-quinolone (4) on the Ab fibrillation. A b 42 peptide solutions were incubated in the presence of either compound 3 or 4 and the fibrillation was assessed by thioflavin-T fluorescence assay and atomic force microscopy (AFM). The results indicate that compounds 3 and 4 are inhibitors of Ab fibrillization, being the latter more potent. Quinolone 4 also promotes the disaggregation of pre-formed Aβ fibrils. We concluded that both compounds interfere with the fibrillization process.
To read the full article Peer-reviewed Article PDF
Author(s): Paula Cristina Huber Gabriella Pitondo Reis Carlos Eduardo Benevento Roger Frigrio Castilho and Wanda Pereira Almeida
Alzheimer´s disease, b-amyloid, levofloxacin, quinolones, fibrillation, levofloxacin